Cytomegalovirus Breakthrough and Resistance During Letermovir Prophylaxis Science in Seattle, 30 Jan 2023 Letermovir is a relatively new antiviral for prophylaxis against cytomegalovirus (CMV) after allogeneic hematopoietic cell…